)
Daniel Burgin
CEO,
T3 BIOSCIENCE
Burgin was appointed as T3’s CEO in late 2016, and is responsible for T3’s business and commercialization strategy. Prior to T3, he had 30+ years’ experience in global capital markets and was the founder & CEO of his own start-up that was successfully sold to the NYSE group in 2011.
Sessions
-
Start-Up Pitching // Biotechnology, Biologicals & Genetics17-Mar-2026Start-Up Arena
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)